Results 161 to 170 of about 15,175 (215)

Cutaneous Eruptions as a Consequence of Myeloid Leukemic Infiltration: Differential Diagnosis With a Benign Dermatosis. [PDF]

Cureus
Duarte TS, Matos CL, Martins RC.
europepmc   +1 more source

Predominant Merkel Cell Polyomavirus DNA Detection in Essential Thrombocythemia within Myeloproliferative Neoplasms. [PDF]

Cancer Res Commun
Liu D, Wang SJ, Macamo A, Severens K, Abdul-Hamid M, Winnepenninckx V, Leers MPG, Zur Hausen A.   +7 more
europepmc   +1 more source

Physiological MplW514L expression in hematopoietic stem cell causes an essential thrombocythemia and progressive myelofibrosis. [PDF]

J Clin Invest
Zhang S, Liu J, Li Y, Wang Y, Wang L, Xu M, Li Y, Dong G, Wang S, Li Y, Cai Z, Zhao B.   +11 more
europepmc   +1 more source

Conflating polycythemia vera with essential thrombocytosis. [PDF]

Blood Adv
Spivak JL.
europepmc   +1 more source

Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia

, 2009
Giannouli, S, Dahabreh, IJ, Zoi, K, Zoi, C, Voulgarelis, M, Loukopoulos, D   +5 more
core  

Some of the next articles are maybe not open access.

Related searches:

Essential Thrombocythemia

Seminars in Hematology, 2005
Significant progress in our understanding of the molecular pathogenesis of essential thrombocythemia (ET) and the other Philadelphia (Ph) chromosome-negative myeloproliferative disorders (MPDs) has recently been achieved. Unfortunately, the diagnosis of ET still relies on a set of exclusion criteria developed years ago, as recent advances have yet to ...
Guido, Finazzi, Claire, Harrison
openaire   +4 more sources

Management of Essential Thrombocythemia

Critical Reviews in Oncology/Hematology, 1999
3. Risk stratification of patients with ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.1. Bleeding and thrombosis in ET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 258 3.2. Risk factors for major bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 259 3.3. Risk factors for thrombosis. .
T, Barbui, G, Finazzi
openaire   +2 more sources

Essential thrombocythaemia

Best Practice & Research Clinical Haematology, 2003
Essential thrombocythaemia is a myeloproliferative disorder that results from the transformation of a multipotent haematopoietic progenitor. Its diagnosis can be challenging and its optimal management has been controversial, largely because of a virtual absence of randomised trials.
Claire N, Harrison, Anthony R, Green
openaire   +3 more sources

Stroke in essential thrombocythemia

Journal of the Neurological Sciences, 2014
Our aim was to assess the incidence and the special characteristics of stroke, as a severe complication of patients diagnosed with essential thrombocythemia (ET).A retrospective analysis was carried out on 102 patients with ET enrolled and analyzed from the period between 1999 and 2012. Patients with one or more strokes were selected.
Pósfai Éva, Marton Imelda, Szőke Anita, Borbényi Zita, Vécsei László, Csomor Angéla, Sas Katalin   +6 more
openaire   +3 more sources